Gene: KCNIP2
Official Full Name: potassium voltage-gated channel interacting protein 2provided by HGNC
Gene Summary: This gene encodes a member of the family of voltage-gated potassium (Kv) channel-interacting proteins (KCNIPs), which belongs to the recoverin branch of the EF-hand superfamily. Members of the KCNIP family are small calcium binding proteins. They all have EF-hand-like domains, and differ from each other in the N-terminus. They are integral subunit components of native Kv4 channel complexes. They may regulate A-type currents, and hence neuronal excitability, in response to changes in intracellular calcium. Multiple alternatively spliced transcript variants encoding distinct isoforms have been identified from this gene. [provided by RefSeq, Jul 2008]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO26746 | KCNIP2 Knockout cell line (HCT 116) | Human | KCNIP2 | 1:2~1:4 | Negative | Online Inquiry |
KO26747 | KCNIP2 Knockout cell line (HEK293) | Human | KCNIP2 | 1:3~1:6 | Negative | Online Inquiry |
KCNIP2 Gene Knockout Cell Lines are genetically modified cellular models designed to lack the KCNIP2 gene, which encodes for a member of the neuronal calcium sensor (NCS) protein family. By creating targeted deletions of this specific gene, these knockout cell lines serve as vital tools for investigating the physiological and pathophysiological roles of KCNIP2 in neuronal function, synaptic signaling, and calcium homeostasis. The disruption of the KCNIP2 gene provides researchers with a unique in vitro platform to study its implications in diseases related to neurodegeneration, synaptic dysfunction, and various neuropsychiatric disorders.
These cell lines function by utilizing CRISPR-Cas9 genome editing technology, which allows for precise gene modification at the nucleotide level. This technique ensures that researchers can accurately assess the effects of knocking out the KCNIP2 gene on cellular behaviors like neurotransmitter release, cellular excitability, and calcium dynamics. As a result, insights gained from these studies can profoundly influence our understanding of neurological diseases and lead to potential therapeutic targets.
The scientific importance of KCNIP2 knockout cell lines extends to both basic research and clinical applications. In research settings, these cell lines could facilitate the development of targeted drugs that modulate calcium signaling within neurons. In clinical environments, understanding the involvement of KCNIP2 in neural pathology can lead to novel diagnostic tools and therapeutic strategies for patients suffering from related conditions.
Compared to alternative models such as wild-type or less-specific knockouts, KCNIP2 Gene Knockout Cell Lines provide a focused examination of a gene with established relevance in neuronal health. Their robust performance in experimental applications, coupled with their high relevance to current neurological research, sets them apart from other cell line models.
For researchers and clinicians alike, the value of KCNIP2 Gene Knockout Cell Lines lies in their ability to unveil complex interactions within neurobiology and refine current understanding of neural mechanisms. With a commitment to excellence in biological products, our company offers high-quality, validated KCNIP2 knockout cell lines that support innovative research endeavors, contributing to advancements in neuroscience and medicine.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.